The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MSI-low is an intermediate type between MSI-high and MSS in esophagogastric junction adenocarcinoma.
 
Yu Imamura
No Relationships to Disclose
 
Tasuku Toihata
No Relationships to Disclose
 
Manabu Takamatsu
No Relationships to Disclose
 
Norio Tanaka
No Relationships to Disclose
 
Shinji Mine
No Relationships to Disclose
 
Seiichi Mori
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Masaru Morita
No Relationships to Disclose
 
Hideo Baba
Honoraria - Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Takeshi Sano
Speakers' Bureau - Chugai Pharma; Johnson & Johnson; Lilly Japan; Medtronic; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Masayuki Watanabe
No Relationships to Disclose